Clinical Trials Browser

Interventional × Central Nervous System Neoplasms × ridaforolimus × Clear all

NCT00704054 2015-02-13

A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)

Phase 1 Completed

Lymphoma, Central Nervous System Neoplasms